Ubiquitin–proteasome system (UPS) as a target for anticancer treatment

J Park, J Cho, EJ Song - Archives of pharmacal research, 2020 - Springer
The ubiquitin–proteasome system (UPS) plays an important role in the cellular processes for
protein quality control and homeostasis. Dysregulation of the UPS has been implicated in …

Beyond K48 and K63: non-canonical protein ubiquitination

M Tracz, W Bialek - Cellular & molecular biology letters, 2021 - Springer
Protein ubiquitination has become one of the most extensively studied post-translational
modifications. Originally discovered as a critical element in highly regulated proteolysis …

Ubiquitin–proteasome system as a target for anticancer treatment—an update

YJ Kim, Y Lee, H Shin, SA Hwang, J Park… - Archives of pharmacal …, 2023 - Springer
As the ubiquitin–proteasome system (UPS) regulates almost every biological process, the
dysregulation or aberrant expression of the UPS components causes many pathological …

Targeting the ubiquitin-proteasome system for cancer therapeutics by small-molecule inhibitors

G LaPlante, W Zhang - Cancers, 2021 - mdpi.com
Simple Summary The ubiquitin-proteasome system regulates multiple facets of protein
homeostasis to modulate signal transduction in numerous biological processes. Not …

UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology

M Mondal, D Conole, J Nautiyal, EW Tate - British journal of cancer, 2022 - nature.com
Breast cancer has the highest incidence and death rate among cancers in women
worldwide. In particular, metastatic estrogen receptor negative (ER–) breast cancer and …

The ubiquitin–proteasome system in breast cancer

D Han, L Wang, S Jiang, Q Yang - Trends in molecular medicine, 2023 - cell.com
Ubiquitin–proteasome system (UPS) is a selective proteolytic system that is associated with
the expression or function of target proteins and participates in various physiological and …

Protein homeostasis in aging and cancer

XQ Chen, T Shen, SJ Fang, XM Sun, GY Li… - Frontiers in Cell and …, 2023 - frontiersin.org
Aging is a major risk factor for cancer development. As dysfunction in protein homeostasis,
or proteostasis, is a universal hallmark of both the aging process and cancer, a …

Dysregulation of the ubiquitin proteasome system in human malignancies: a window for therapeutic intervention

CW Fhu, A Ali - Cancers, 2021 - mdpi.com
Simple Summary The ubiquitin proteasome system (UPS) governs the non-lysosomal
degradation of oxidized, damaged, or misfolded proteins in eukaryotic cells. Dysregulation …

From molecular pathogenesis to therapy: Unraveling non-coding RNAs/DNMT3A axis in human cancers

C Huang, SM Aghaei-Zarch - Biochemical Pharmacology, 2024 - Elsevier
Cancer is a comprehensive classification encompassing more than 100 forms of
malignancies that manifest in diverse tissues within the human body. Recent studies have …

Research progress of Nedd4L in cardiovascular diseases

M Li, G Sun, P Wang, W Wang, K Cao, C Song… - Cell death …, 2022 - nature.com
Post-translational modifications (PTMs) are a covalent processing process of proteins after
translation. Proteins are capable of playing their roles only after being modified, so as to …